Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

Tirzepatide is a weight loss drug for adults with obesity or with overweight who also have weight-related medical problems, as Zepbound in the US and Mounjaro in some countries outside of the US ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Stock markets rally as US and China agree to slash tariffs for at least 90 days. Also: Kurdish PKK militants end armed struggle against Turkey and Mounjaro and Wegovy go head to head in weight loss ...

Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

Both the Mounjaro and Wegovy jabs used in the trial were found to be effective treatments for patients with obesity, but one ...